Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 23-Apr-24 5:25 PM View:  | Korro Bio, Inc. (KRRO) | 22-Apr-24 | Grant | 17,857 | $56.00 | $999,992.00 | 2% 1.12M to 1.14M | |
| 07-Nov-23 9:09 PM View: | Korro Bio, Inc. (KRRO) | 03-Nov-23 | Grant | 1,119,290 | -- | -- | 100% 0 to 1.12M | |
| 16-Jun-22 6:33 PM View: | Intellia Therapeutics, Inc. (NTLA) | 14-Jun-22 | Grant | 5,197 | -- | -- | 248% 2.09K to 7.29K | |
| 14-Dec-21 8:29 PM View: | Ikena Oncology, Inc. (IKNA) | 14-Dec-21 | Market Sale Duplicate | 5,959 | $14.00 | $83,426.00 | (< 1%) 5.02M to 5.02M | |
| 14-Dec-21 8:29 PM View: | Ikena Oncology, Inc. (IKNA) | 13-Dec-21 | Market Sale Duplicate | 8,330 | $14.64 | $121,951.00 | (< 1%) 5.03M to 5.02M | |
| 14-Dec-21 8:29 PM View: | Ikena Oncology, Inc. (IKNA) | 10-Dec-21 | Market Sale Duplicate | 11,989 | $15.03 | $180,195.00 | (< 1%) 5.04M to 5.03M | |
| 14-Sep-21 7:23 PM View: | Translate Bio, Inc. (TBIO) | 14-Sep-21 | Market Sale (Planned) | 2,055,060 | $38.00 | $78,092,400.00 | (100%) 2.06M to 0 | 2% |
| 29-Jun-21 9:48 AM View: | Intellia Therapeutics, Inc. (NTLA) | 28-Jun-21 | Market Sale | 553,376 | $132.73 | $73,448,896.00 | (98%) 563.38K to 10.0K | (< 1%) |
| 25-Jun-21 6:05 PM View: | Intellia Therapeutics, Inc. (NTLA) | 23-Jun-21 | Grant | 2,094 | -- | -- | 100% 0 to 2.09K | |
| 15-Jun-21 9:51 AM View: | Intellia Therapeutics, Inc. (NTLA) | 14-Jun-21 | Market Sale | 170,779 | $87.37 | $14,921,300.00 | (13%) 1.3M to 1.13M | (< 1%) |
| 15-Jun-21 9:51 AM View: | Intellia Therapeutics, Inc. (NTLA) | 11-Jun-21 | Market Sale | 30,946 | $85.23 | $2,637,480.00 | (2%) 1.33M to 1.3M | (3%) |
| 30-Apr-21 8:55 PM View: | Intellia Therapeutics, Inc. (NTLA) | 29-Apr-21 | Market Sale | 4,513 | $85.43 | $385,546.00 | (< 1%) 769.61K to 765.1K | 6% |
| 28-Apr-21 7:51 PM View: | Intellia Therapeutics, Inc. (NTLA) | 28-Apr-21 | Market Sale | 131,926 | $85.56 | $11,287,900.00 | (15%) 901.54K to 769.61K | (2%) |
| 28-Apr-21 7:51 PM View: | Intellia Therapeutics, Inc. (NTLA) | 27-Apr-21 | Market Sale | 210,230 | $86.22 | $18,126,000.00 | (19%) 1.11M to 901.54K | (< 1%) |
| 28-Apr-21 7:51 PM View: | Intellia Therapeutics, Inc. (NTLA) | 26-Apr-21 | Market Sale | 806 | $84.93 | $68,453.60 | (< 1%) 1.11M to 1.11M | (3%) |
| 07-Apr-21 2:14 PM View: | Intellia Therapeutics, Inc. (NTLA) | 05-Apr-21 | Market Sale | 800 | $84.98 | $67,984.00 | (< 1%) 1.11M to 1.11M | 6% |
| 01-Apr-21 6:23 PM View: | Ikena Oncology, Inc. (IKNA) | 30-Mar-21 | Conversion Duplicate | 4,750,360 | -- | -- | 2809% 169.1K to 4.92M | |
| 14-Dec-21 8:29 PM View: | Ikena Oncology, Inc. (IKNA) | 30-Mar-21 | Purchase Duplicate | 125,000 | $16.00 | $2,000,000.00 | 3% 4.92M to 5.04M | |
| 01-Mar-21 1:59 PM View: | Intellia Therapeutics, Inc. (NTLA) | 26-Feb-21 | Market Sale | 501,945 | $60.29 | $30,262,700.00 | (31%) 1.62M to 1.11M | (< 1%) |
| 23-Dec-20 6:07 PM View: | Translate Bio, Inc. (TBIO) | 22-Dec-20 | Market Sale (Planned) | 82,565 | $25.07 | $2,069,870.00 | (3%) 2.78M to 2.7M | 12% |
| 23-Dec-20 6:07 PM View: | Translate Bio, Inc. (TBIO) | 21-Dec-20 | Market Sale (Planned) | 56,536 | $25.50 | $1,441,930.00 | (2%) 2.84M to 2.78M | 13% |
| 27-Aug-20 8:14 PM View: | Translate Bio, Inc. (TBIO) | 27-Aug-20 | Market Sale | 10,097 | $14.38 | $145,217.00 | (< 1%) 3.84M to 3.83M | (54%) |
| 27-Aug-20 8:14 PM View: | Translate Bio, Inc. (TBIO) | 26-Aug-20 | Market Sale | 44,381 | $14.80 | $656,746.00 | (1%) 3.89M to 3.84M | (50%) |
| 27-Aug-20 8:14 PM View: | Translate Bio, Inc. (TBIO) | 25-Aug-20 | Market Sale | 34,410 | $15.00 | $516,160.00 | (< 1%) 3.92M to 3.89M | (48%) |
| 18-Jul-18 8:40 AM View: | Intellia Therapeutics, Inc. (NTLA) | 16-Jul-18 | Market Sale | 6,686 | $31.17 | $208,397.00 | (< 1%) 1.62M to 1.62M | (99%) |
| 03-Jul-18 6:37 PM View: | Translate Bio, Inc. (TBIO) | 02-Jul-18 | Conversion Duplicate | 3,832,010 | -- | -- | 4258% 90.0K to 3.92M | |
| 20-Jun-18 12:03 PM View: | Intellia Therapeutics, Inc. (NTLA) | 19-Jun-18 | Market Sale | 6,686 | $27.96 | $186,908.00 | (< 1%) 1.84M to 1.84M | (122%) |
| 17-May-18 10:47 AM View: | Intellia Therapeutics, Inc. (NTLA) | 16-May-18 | Market Sale | 6,686 | $25.04 | $167,389.00 | (< 1%) 2.06M to 2.06M | (148%) |
| 22-Mar-18 1:43 PM View: | Intellia Therapeutics, Inc. (NTLA) | 20-Mar-18 | Market Sale | 39,245 | $23.87 | $936,743.00 | (2%) 2.32M to 2.28M | (160%) |
| 07-Nov-17 4:08 PM View: | Spero Therapeutics, Inc. (SPRO) | 06-Nov-17 | Conversion | 1,936,780 | -- | -- | 136% 1.42M to 3.36M | |
| 07-Nov-17 4:08 PM View: | Spero Therapeutics, Inc. (SPRO) | 06-Nov-17 | Purchase Duplicate | 428,571 | $14.00 | $5,999,990.00 | 13% 3.36M to 3.79M | |
| 11-Jul-17 5:40 PM View: | Intellia Therapeutics, Inc. (NTLA) | 11-Jul-17 | Market Sale Duplicate | 80,000 | $16.07 | $1,285,560.00 | (2%) 3.66M to 3.58M | (286%) |
| 11-Jul-17 5:40 PM View: | Intellia Therapeutics, Inc. (NTLA) | 10-Jul-17 | Market Sale Duplicate | 40,000 | $16.17 | $646,888.00 | (1%) 3.7M to 3.66M | (284%) |
| 11-Jul-17 5:40 PM View: | Intellia Therapeutics, Inc. (NTLA) | 07-Jul-17 | Market Sale Duplicate | 30,000 | $16.77 | $502,992.00 | (< 1%) 3.73M to 3.7M | (270%) |
| 13-Mar-17 10:34 AM View: | Intellia Therapeutics, Inc. (NTLA) | 10-Mar-17 | Market Sale Duplicate | 5,504 | $14.06 | $77,410.50 | (< 1%) 3.74M to 3.73M | (341%) |
| 13-Mar-17 10:34 AM View: | Intellia Therapeutics, Inc. (NTLA) | 09-Mar-17 | Market Sale Duplicate | 15,628 | $13.85 | $216,432.00 | (< 1%) 3.75M to 3.74M | (348%) |
| 11-May-16 7:01 PM View: | Intellia Therapeutics, Inc. (NTLA) | 11-May-16 | Conversion Duplicate | 4,429,790 | -- | -- | 100% 0 to 4.43M | |
| 12-Feb-14 3:01 PM View: | Zyla Life Sciences (ZCOR) | 11-Feb-14 | Conversion Duplicate | 2,080,560 | $1.11 | $2,302,220.00 | 674% 308.72K to 2.39M | |
| 12-Feb-14 3:01 PM View: | Zyla Life Sciences (ZCOR) | 11-Feb-14 | Purchase Duplicate | 41,667 | $12.00 | $500,004.00 | 2% 2.39M to 2.43M | |
| 12-Feb-14 3:01 PM View: | Zyla Life Sciences (ZCOR) | 11-Feb-14 | Exercise (in-the money or at-the-money) Duplicate | 30,000 | $0.00 | $30.00 | 1% 2.43M to 2.46M | |
| 24-Oct-12 9:05 PM View: | Nuvelo Inc. (ABIO) | 22-Oct-12 | Grant Duplicate | 317,379 | $0.39 | $125,016.00 | 25% 1.26M to 1.58M | |
| 06-Mar-12 3:28 PM View: | Horizon Pharma, Inc. (HZNP) | 02-Mar-12 | Market Purchase | 828,443 | $3.62 | $2,999,960.00 | 29% 2.86M to 3.69M | 436% |
| 04-Aug-11 5:13 PM View: | Horizon Pharma, Inc. (HZNP) | 02-Aug-11 | Conversion Duplicate | 2,163,510 | $1.69 | $3,653,590.00 | 19% 11.23M to 13.4M | |
| 04-Aug-11 5:13 PM View: | Horizon Pharma, Inc. (HZNP) | 02-Aug-11 | Market Purchase Duplicate | 369,814 | $9.00 | $3,328,330.00 | 3% 13.4M to 13.77M | 116% |
| 31-Mar-10 3:05 PM View: | Nuvelo Inc. (ABIO) | 29-Mar-10 | Market Sale Duplicate | 140,000 | $7.56 | $1,058,400.00 | (9%) 1.48M to 1.34M | 100% |
| 02-Nov-06 3:29 PM View: | Achillion Pharmaceuticals, ... (ACHN) | 31-Oct-06 | Conversion Duplicate | 1,968,670 | -- | -- | 100% 0 to 1.97M | |
| 31-May-06 10:00 PM View: | Nxstage Medical, Inc. (NXTM) | 26-May-06 | Payment of Exercise | 6,795 | $10.95 | $74,405.20 | (< 1%) 2.6M to 2.59M | (189%) |
| 31-May-06 10:00 PM View: | Nxstage Medical, Inc. (NXTM) | 26-May-06 | Exercise (in-the money or at-the-money) | 10,434 | $7.13 | $74,394.40 | < 1% 2.59M to 2.6M | |
| 07-Feb-06 9:24 PM View: | SGX Pharmaceuticals, Inc. (SGXP) | 06-Feb-06 | Conversion Duplicate | 2,068,400 | -- | -- | 496% 416.67K to 2.49M | |
| 03-Feb-06 11:18 AM View: | SGX Pharmaceuticals, Inc. (SGXP) | 01-Feb-06 | Purchase Duplicate | 416,666 | $6.00 | $2,500,000.00 | 100% 0 to 416.67K | (76%) |